ciprofloxacin has been researched along with Aneurysm, Thoracic Aortic in 6 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin increases susceptibility to aortic dissection and rupture in a mouse model of moderate, sporadic AAD." | 7.88 | Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice. ( Azares, AR; Coselli, JS; LeMaire, SA; Luo, W; Ren, P; Shen, YH; Wang, Y; Zhang, C; Zhang, L, 2018) |
| "Based on 3721 adverse event reports, all three fluoroquinolones are associated with aortic aneurysm, and levofloxacin is associated with aortic dissection." | 3.91 | Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system. ( Huang, H; Huang, J; Jia, Y; Meng, L; Qiu, F; Sun, S, 2019) |
| "Ciprofloxacin increases susceptibility to aortic dissection and rupture in a mouse model of moderate, sporadic AAD." | 3.88 | Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice. ( Azares, AR; Coselli, JS; LeMaire, SA; Luo, W; Ren, P; Shen, YH; Wang, Y; Zhang, C; Zhang, L, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Xiang, B | 2 |
| Abudupataer, M | 2 |
| Liu, G | 2 |
| Zhou, X | 2 |
| Liu, D | 2 |
| Zhu, S | 2 |
| Ming, Y | 2 |
| Yin, X | 2 |
| Yan, S | 2 |
| Sun, Y | 2 |
| Lai, H | 2 |
| Wang, C | 2 |
| Li, J | 2 |
| Zhu, K | 2 |
| LeMaire, SA | 1 |
| Zhang, L | 1 |
| Luo, W | 1 |
| Ren, P | 1 |
| Azares, AR | 1 |
| Wang, Y | 1 |
| Zhang, C | 1 |
| Coselli, JS | 1 |
| Shen, YH | 1 |
| Nagiah, S | 1 |
| Badbess, R | 1 |
| Meng, L | 1 |
| Huang, J | 1 |
| Jia, Y | 1 |
| Huang, H | 1 |
| Qiu, F | 1 |
| Sun, S | 1 |
| Schoevaerdts, D | 1 |
| Hanon, F | 1 |
| Vanpee, D | 1 |
| Swine, C | 1 |
| Glupczynski, Y | 1 |
| Vander Borght, T | 1 |
| Marchandise, B | 1 |
| John, R | 1 |
| Korula, RJ | 1 |
| Lal, N | 1 |
| Shukla, V | 1 |
| Lalitha, MK | 1 |
1 review available for ciprofloxacin and Aneurysm, Thoracic Aortic
| Article | Year |
|---|---|
Salmonellosis complicating aortic aneurysms.
Topics: Aneurysm, Infected; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Ciprofloxacin; Humans; Ma | 1994 |
5 other studies available for ciprofloxacin and Aneurysm, Thoracic Aortic
| Article | Year |
|---|---|
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice.
Topics: Animals; Anti-Bacterial Agents; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Cells | 2018 |
Unexpected source of
Topics: Aged, 80 and over; Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Thoracic; Bacteremia; | 2018 |
Assessing fluoroquinolone-associated aortic aneurysm and dissection: Data mining of the public version of the FDA adverse event reporting system.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aortic Aneurysm, Thoracic; Aortic | 2019 |
Prolonged survival of an elderly woman with Salmonella dublin aortitis and conservative treatment.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Aortic Aneurysm, Thoracic; Aortitis; Ciprofloxacin; | 2003 |